Quick Facts
  • wavy circle icon with check mark inside
    Pleural Mesothelioma
    Lung Cancer
    Thymic Epithelial Tumors
    Esophageal Cancer
    Minimally Invasive Thoracic Surgery
  • certificate with a ribbon icon below
    American Board of Thoracic Surgery
    American Board of Surgery
  • magnifying glass with heart icon
    Pleural Mesothelioma
  • gender symbols interlocked icon

About Dr. Chuong Hoang

Thoracic surgeon Dr. Chuong Hoang is leading a research team in developing new therapeutic strategies for thoracic malignancies for non-small cell lung cancer, thymic epithelial tumors and pleural mesothelioma.

His most recent work is an intraoperative, spray-on hydrogel involving genetically engineered nanoparticles with the ability to specifically target and kill tumor cells.

Although still in its early stages of development, Hoang believes it could become a much-needed, long-awaited breakthrough in treating mesothelioma.

“I’m excited by what we’ve seen so far,” Hoang said. “This could become a huge deal, a real game-changer in treating this disease.”

Hoang’s clinical expertise in thoracic surgery includes thymic tumors, tracheal cancers, esophageal cancer, pulmonary metastasis and mesothelioma. He often uses minimally invasive robotic surgery.

Before joining the National Cancer Institute, Hoang was an assistant professor at the Stanford University School of Medicine and medical director of the Stanford Cancer Center Tissue Bank. He also established a thoracic oncology laboratory investigating microRNA interactions in mesothelioma.

Hoang’s research projects include ongoing investigations of how malignant mesothelioma tumors develop and the role of microRNA in treating mesothelioma.

Dr. Hoang’s Role as an Expert Contributor on Asbestos.com

Hoang’s extensive experience and expertise in researching and treating mesothelioma make him a perfect fit to review pages and author articles for Asbestos.com. His deep understanding of how mesothelioma forms and progresses, as well as methods to treat it, qualify him as a respected expert in the field. 

His help has been critical in assuring that content on these pages remains current, consistent and medically correct, making The Mesothelioma Center at Asbestos.com the nation’s most trusted mesothelioma resource.

Specialties of Dr. Chuong Hoang

  • Endocrine and neuroendocrine
  • Esophageal cancer
  • Lung cancer
  • Mesothelioma
  • Pulmonary metastatic cancers
  • RNA biology

Experience and Medical Education

  • Center for Cancer Research at National Cancer Institute, Investigator
  • Stanford University School of Medicine, Assistant Professor
  • Stanford Cancer Center Tissue Bank, Medical Director
  • University of Pennsylvania (Cardiothoracic Residency)
  • University of Minnesota Medical School (M.D. and Surgical Residency)

Awards and Recognition

  • Ruth L. Kirschstein National Research Service Award
  • Training Program Grant, Division of Hematology-Oncology

Dr. Chuong Hoang’s Publications

  • Majumder, P. et al. (2021). Surface-fill Hydrogel Attenuates the Oncogenic Signature of Complex Anatomical Surface Cancer in a Single Application.
  • Singh, A. et al. (2021). MicroRNA-206 Suppresses Mesothelioma Progression Via the Ras Signaling Axis.
  • Pruett, N. et al. (2020). Normal Mesothelial Cell Lines Newly Derived from Human Pleural Biopsy Explants.
  • Singh, A. et al. (2019). MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis
  • Zhang, L. et al. (2019). Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling.